These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 17077605

  • 21. No nephropathy in Type 2 diabetic patient with POEMS syndrome with an elevated plasma VEGF.
    Baba T, Østerby R, Neugebauer-Baba S, Nozawa Y, Watanabe T, Sakurai K, Katoh T, Watanabe T.
    Diabet Med; 2004 Mar; 21(3):292-4. PubMed ID: 15008843
    [Abstract] [Full Text] [Related]

  • 22. Development of Polyneuropathy, Organomegaly, Endocrinopathy, M Protein, and Skin Changes Syndrome after Conversion from Plasmacytoma of Bone to Multiple Myeloma.
    Hatano K, Orimo K, Ogura M, Okabe S, Ishida T, Kubota A, Shimizu J, Hashida H.
    Intern Med; 2023 Feb 01; 62(3):475-479. PubMed ID: 35831107
    [Abstract] [Full Text] [Related]

  • 23. [POEMS syndrome diagnosed by detection of M-protein on immunofixation and increased level of vascular endothelial growth factor].
    Hattori Y, Taguchi J, Imai N, Wasano K, Matsuura S, Koharazawa H, Ishigatsubo Y, Fujisawa S.
    Rinsho Ketsueki; 2011 Apr 01; 52(4):219-22. PubMed ID: 21566409
    [Abstract] [Full Text] [Related]

  • 24. Skin manifestations and vascular endothelial growth factor levels in POEMS syndrome: impact of autologous hematopoietic stem cell transplantation.
    Barete S, Mouawad R, Choquet S, Viala K, Leblond V, Musset L, Amoura Z, Khayat D, Francès C.
    Arch Dermatol; 2010 Jun 01; 146(6):615-23. PubMed ID: 20566924
    [Abstract] [Full Text] [Related]

  • 25. Increase of serum vascular endothelial growth factors in wet beriberi: two case reports.
    Imai N, Kubota M, Saitou M, Yagi N, Serizawa M, Kobari M.
    Intern Med; 2012 Jun 01; 51(8):929-32. PubMed ID: 22504253
    [Abstract] [Full Text] [Related]

  • 26. Changes in subfoveal choroidal thickness and reduction of serum levels of vascular endothelial growth factor in patients with POEMS syndrome.
    Yokouchi H, Baba T, Misawa S, Kitahashi M, Oshitari T, Kuwabara S, Yamamoto S.
    Br J Ophthalmol; 2017 Jun 01; 101(6):786-790. PubMed ID: 27707692
    [Abstract] [Full Text] [Related]

  • 27. [Crow-Fukase (POEMS) syndrome].
    Kuwabara S.
    Brain Nerve; 2010 Apr 01; 62(4):395-400. PubMed ID: 20420180
    [Abstract] [Full Text] [Related]

  • 28. Failure of treatment with anti-VEGF monoclonal antibody for long-standing POEMS syndrome.
    Kanai K, Kuwabara S, Misawa S, Hattori T.
    Intern Med; 2007 Apr 01; 46(6):311-3. PubMed ID: 17380000
    [Abstract] [Full Text] [Related]

  • 29. [A patient with Crow-Fukase syndrome associated with pulmonary plasmacytoma].
    Shinde A, Matsumae H, Maruyama A, Oida J, Kawamoto Y, Kouhara N, Oka N, Shirase T, Kitaichi M, Akiguchi I, Shibasaki H.
    Rinsho Shinkeigaku; 2001 Apr 01; 41(2-3):121-5. PubMed ID: 11481854
    [Abstract] [Full Text] [Related]

  • 30. An atypical presentation of POEMS syndrome with IgG kappa type M protein and normal VEGF level: Case report and review of literature.
    Pulivarthi S, Gurram MK.
    J Cancer Res Ther; 2018 Apr 01; 14(3):679-681. PubMed ID: 29893339
    [Abstract] [Full Text] [Related]

  • 31. Correlation between peripapillary retinal thickness and serum level of vascular endothelial growth factor in patients with POEMS syndrome.
    Yokouchi H, Baba T, Misawa S, Sawai S, Kitahashi M, Oshitari T, Kuwabara S, Yamamoto S.
    Br J Ophthalmol; 2016 Jul 01; 100(7):897-901. PubMed ID: 26504179
    [Abstract] [Full Text] [Related]

  • 32. [Crow-Fukase (POEMS) syndrome: pathophysiology and treatments].
    Kuwabara S.
    Nihon Rinsho; 2013 May 01; 71(5):865-9. PubMed ID: 23777096
    [Abstract] [Full Text] [Related]

  • 33. [A case of Crow-Fukase syndrome showing improvement following excision and irradiation of bone lesions].
    Yoritaka A, Sakai M, Ohta K, Kishida S.
    Rinsho Shinkeigaku; 2004 Jun 01; 44(6):369-71. PubMed ID: 15293761
    [Abstract] [Full Text] [Related]

  • 34. Polyneuropathy in POEMS syndrome: role of angiogenic factors in the pathogenesis.
    Scarlato M, Previtali SC, Carpo M, Pareyson D, Briani C, Del Bo R, Nobile-Orazio E, Quattrini A, Comi GP.
    Brain; 2005 Aug 01; 128(Pt 8):1911-20. PubMed ID: 15975949
    [Abstract] [Full Text] [Related]

  • 35. Remarkable expression of vascular endothelial growth factor in bone marrow plasma cells of patients with POEMS syndrome.
    Wang C, Huang XF, Cai QQ, Cao XX, Cai H, Zhou D, Li J.
    Leuk Res; 2016 Nov 01; 50():78-84. PubMed ID: 27697660
    [Abstract] [Full Text] [Related]

  • 36. The Crow-Fukase syndrome: a study of 102 cases in Japan.
    Nakanishi T, Sobue I, Toyokura Y, Nishitani H, Kuroiwa Y, Satoyoshi E, Tsubaki T, Igata A, Ozaki Y.
    Neurology; 1984 Jun 01; 34(6):712-20. PubMed ID: 6539431
    [Abstract] [Full Text] [Related]

  • 37. Plasma cell dyscrasia with polyneuropathy--POEMS syndrome presenting with vasculitic skin lesions and responding to combination chemotherapy.
    Sharabi Y, Raanani P, Shenkar A, Thaler M, Grossman E.
    Leuk Lymphoma; 2000 Dec 01; 40(1-2):209-13. PubMed ID: 11426623
    [Abstract] [Full Text] [Related]

  • 38. Predictive value of serial platelet count and VEGF determination for the management of DIC in the Crow-Fukase (POEMS) syndrome.
    Tokashiki T, Hashiguchi T, Arimura K, Eiraku N, Maruyama I, Osame M.
    Intern Med; 2003 Dec 01; 42(12):1240-3. PubMed ID: 14714967
    [Abstract] [Full Text] [Related]

  • 39. Crow-Fukase syndrome.
    Koike H, Sobue G.
    Neuropathology; 2000 Sep 01; 20 Suppl():S69-72. PubMed ID: 11037192
    [Abstract] [Full Text] [Related]

  • 40. Pentraxin-3 and VEGF in POEMS syndrome: a 2-year longitudinal study.
    Briani C, Dalla Torre C, Lessi F, Cavallaro T, Scarlato M, Ferrari S, Campagnolo M, Lucchetta M, Cabrini I, Morbin M, Lauria G, Adami F, Manfredi AA.
    J Neuroimmunol; 2014 Dec 15; 277(1-2):189-92. PubMed ID: 25447599
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.